Tradestie Institutional Equity Comparison Engine

CLX vs UL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CLX Overall Edge

CLX Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Clorox Company (CLX) driven by superior Valuation, Momentum & Technical, Options & Structure while UL counters with relative strength in Growth & Margin. Fundamentally, CLX trades at 17.6x Forward P/E with 14.3% operating margin (+33.3% YoY revenue) versus UL at 18.5x Forward P/E and 20.0% operating margin (+0.5% YoY). In options structure, CLX sits in SURGE (25th %ile IV; Dealer Gamma Walls on Pro) against UL sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CLX
CLX 17.6x vs UL 18.5x Fwd P/E
Growth & Margin Winner UL
Op Margin 14.3% vs 20.0% ยท YoY +33.3% vs +0.5%
Momentum & Technical Winner CLX
1Y +6.4% vs +8.4% ยท 52W Pos 51% vs 45%
Options & Structure Winner CLX
SURGE (25th %ile IV) vs UNCLASSIFIED (13th %ile IV)
CLX NYSE
Clorox Company
Specialty Cleaning, Polishing And Sanitation Preparations
$104.73
-0.16% 1D
Market Cap $12.7B
1M Return +18.13%
1Y Return +6.4%
Forward P/E 17.6x
Unified AI Score
29.7 / 100 SELL
Tech 50.0 Fund 32.0 Flow 57.0 Mom 50.0
UL NYSE
Unilever plc
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.82
+0.73% 1D
Market Cap $136.4B
1M Return -4.75%
1Y Return +8.41%
Forward P/E 18.5x
Unified AI Score
46.7 / 100 HOLD
Tech 47.0 Fund 45.0 Flow 50.0 Mom 36.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CLX +6.4% UL +8.41% Spread: +2.01 pp (UL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CLX TTM Op. Margin: 14.3% UL TTM Op. Margin: 20.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLX vs UL. Trailing 12-month operating profitability (CLX 14.3% vs UL 20.0%) and valuation multiples (CLX 17.6x vs UL 18.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CLX (4) vs UL (6)
Institutional Metric CLX UL Criterion Row Winner
Market Capitalization Scale $12.7B $136.4B Larger Scale UL
Trailing P/E Ratio Valuation 18.9x 13.0x Lower Multiple UL
Forward P/E Ratio Valuation 17.6x 18.5x Lower Multiple CLX
Revenue Growth (YoY) Growth +33.3% +0.5% Higher Growth CLX
Operating Margin (TTM) Profitability 14.3% 20.0% Higher Margin UL
Net Profit Margin Profitability 9.4% 18.3% Higher Margin UL
Return on Equity (ROE) Capital Efficiency 53.4% 31.9% Higher ROE CLX
52-Week Range Position Momentum 51% ($79โ€“$129) 45% ($55โ€“$75) Stronger Trend CLX
Beta / 30D Volatility Risk Regime 0.43ฮฒ ยท 37% Vol -0.03ฮฒ ยท 24% Vol Lower Realized Risk UL
Unified Institutional Score Composite Signal 29.7 / 100 (SELL) 46.7 / 100 (HOLD) Higher Composite UL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CLX vs UL Buy Guide
CLX SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live UL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CLX nor UL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.